Fatty acid metabolism in neutrophils promotes lung damage and bacterial replication during tuberculosis

被引:2
|
作者
Sankar, Poornima [1 ]
Ramos, Ramon Bossardi [2 ]
Corro, Jamie [3 ]
Mishra, Lokesh K. [1 ]
Nafiz, Tanvir Noor [1 ]
Bhargavi, Gunapati [4 ]
Saqib, Mohd [1 ]
Poswayo, Sibongiseni K. L. [5 ,6 ]
Parihar, Suraj P. [5 ,6 ]
Cai, Yi [7 ]
Subbian, Selvakumar [4 ]
Ojha, Anil K. [3 ]
Mishra, Bibhuti B. [1 ]
机构
[1] Albany Med Coll, Dept Immunol & Microbial Dis, Albany, NY 12208 USA
[2] Albany Med Coll, Dept Mol & Cellular Physiol, Albany, NY USA
[3] New York State Dept Hlth, Wadsworth Ctr, Div Genet, Albany, NY USA
[4] Rutgers State Univ, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ USA
[5] Univ Cape Town, Ctr Infect Dis Res Africa CIDRI Africa, Cape Town, South Africa
[6] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med IDM, Div Med Microbiol, Cape Town, South Africa
[7] Shenzhen Univ, Med Sch, Dept Pathogen Biol, Guangdong Key Lab Reg Immun & Dis, Shenzhen, Peoples R China
关键词
IMMUNOPATHOLOGY; INFLAMMATION; NECROSIS; DIVERSE; GAMMA; CELLS;
D O I
10.1371/journal.ppat.1012188
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Mycobacterium tuberculosis (Mtb) infection induces a marked influx of neutrophils into the lungs, which intensifies the severity of tuberculosis (TB). The metabolic state of neutrophils significantly influences their functional response during inflammation and interaction with bacterial pathogens. However, the effect of Mtb infection on neutrophil metabolism and its consequent role in TB pathogenesis remain unclear. In this study, we examined the contribution of glycolysis and fatty acid metabolism on neutrophil responses to Mtb HN878 infection using ex-vivo assays and murine infection models. We discover that blocking glycolysis aggravates TB pathology, whereas inhibiting fatty acid oxidation (FAO) yields protective outcomes, including reduced weight loss, immunopathology, and bacterial burden in lung. Intriguingly, FAO inhibition preferentially disrupts the recruitment of a pathogen-permissive immature neutrophil population (Ly6Glo/dim), known to accumulate during TB. Targeting carnitine palmitoyl transferase 1a (Cpt1a)-a crucial enzyme in mitochondrial beta-oxidation-either through chemical or genetic methods impairs neutrophils' ability to migrate to infection sites while also enhancing their antimicrobial function. Our findings illuminate the critical influence of neutrophil immunometabolism in TB pathogenesis, suggesting that manipulating fatty acid metabolism presents a novel avenue for host-directed TB therapies by modulating neutrophil functions. Tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) is a significant global health issue. Neutrophils, immune cells that rapidly enter the lungs during Mtb infection, contribute both to fighting the infection and exacerbating lung damage. Their metabolic state, especially the way they produce energy, is crucial for their function during TB. However, the specific impact of Mtb on neutrophil metabolism and its role in TB progression has been unclear. In this study, we investigated the roles of glycolysis and fatty acid metabolism in neutrophil responses to Mtb infection. We found that inhibiting glycolysis worsens TB outcomes, while blocking fatty acid oxidation (FAO) provides protection, reducing lung damage, bacterial load, and overall disease severity. Notably, FAO inhibition specifically disrupts the accumulation of an immature neutrophil population that is more susceptible to Mtb, thereby improving infection control. Targeting carnitine palmitoyl transferase 1a (Cpt1a), a key enzyme in fatty acid metabolism, impaired neutrophil migration to infection sites and enhanced their antimicrobial activity. These findings suggest that modulating neutrophil metabolism, particularly through FAO inhibition, could be a promising strategy for developing host-directed TB therapies.
引用
收藏
页数:36
相关论文
共 50 条
  • [1] Defective Fatty Acid Metabolism Promotes Fibrosis in the Lung
    Alvarez, D. M.
    Bueno, M.
    Tu, L.
    Kimball, B.
    Eric, G.
    Rojas, M.
    Mora, A. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [2] Neutrophilic inflammation promotes bacterial growth during Tuberculosis
    Mishra, Bibhuti B.
    Sassetti, Christopher
    JOURNAL OF IMMUNOLOGY, 2016, 196
  • [3] Characterization of Fatty Acid Metabolism in Lung Adenocarcinoma
    Wang, Suyu
    Chen, Aona
    Zhu, Wanli
    Feng, Di
    Wei, Juan
    Li, Quanfu
    Shi, Xuan
    Lv, Xin
    Liu, Meiyun
    FRONTIERS IN GENETICS, 2022, 13
  • [4] Bacterial fatty acid metabolism in modern antibiotic discovery
    Yao, Jiangwei
    Rock, Charles O.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2017, 1862 (11): : 1300 - 1309
  • [5] Asiatic acid promotes liver fatty acid metabolism in diabetic models
    Xu, Guangyuan
    Sun, Wen
    Guo, Xuan
    Wu, Lili
    Hou, Yi
    Ma, Xuesheng
    Qin, Lingling
    Gao, Ming
    Liu, Tonghua
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (11): : 11837 - 11845
  • [6] Fatty acid synthase promotes breast cancer metastasis by mediating changes in fatty acid metabolism
    Xu, Shuo
    Chen, Tingting
    Dong, Lihua
    Li, Tao
    Xue, Hui
    Gao, Bo
    Ding, Xiaodong
    Wang, Hui
    Li, Hua
    ONCOLOGY LETTERS, 2021, 21 (01)
  • [7] Defining the role of neutrophils in the lung during infection: Implications for tuberculosis disease
    Gaffney, E.
    Murphy, D.
    Walsh, A.
    Connolly, S.
    Basdeo, S. A.
    Keane, J.
    Phelan, J. J.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [8] The Role of Fatty Acid Metabolism in Drug Tolerance of Mycobacterium tuberculosis
    Quinonez, Camila G.
    Lee, Jae Jin
    Lim, Juhyeon
    Odell, Mark
    Lawson, Christopher P.
    Anyogu, Amararachukwu
    Raheem, Saki
    Eoh, Hyungjin
    MBIO, 2022, 13 (01):
  • [9] Targeting fatty acid metabolism promotes a healthy vaginal microbiome
    Marchal, Iris
    NATURE BIOTECHNOLOGY, 2024, 42 (09) : 1357 - 1357
  • [10] EFFECT OF PROSTAGLANDINS ON FATTY-ACID METABOLISM IN LUNG
    SCHILLER, HS
    DONABEDIAN, RK
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1974, 5 (04) : 375 - 386